News from merck A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

19 Aug, 2019, 13:00 BST Merck Granted Seven Additional CRISPR Patents, Bringing Total to 20 Worldwide

Merck, a leading science and technology company, today announced that the European, Israeli, South Korean and U.K. intellectual property offices have ...


18 Jul, 2019, 13:00 BST Merck and Broad Institute Announce CRISPR License Framework to Encourage Innovation

Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard (Boston, Massachusetts) today announced an agreement to...


16 Jul, 2019, 08:00 BST Merck's Embracing Carers™ Launches 'Time Counts' to Raise 1 Million Minutes of Support for Carers

Merck, a leading science and technology company, today announced that its Embracing Carers™ initiative has launched 'Time Counts,' a social media-led ...


20 Jun, 2019, 19:33 BST Merck's Massachusetts-based Business Sectors Named 'Best Places to Work' by Boston Business Journal

Merck, a leading science and technology company, today announced that its Massachusetts-based business sectors have been named to the Boston Business ...


22 May, 2019, 13:00 BST Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event

Merck, a leading science and technology company, today hosted a panel discussion on the occasion of the 72nd World Health Assembly in Geneva,...


20 May, 2019, 13:00 BST Merck Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

Merck, a leading science and technology company, today announced its participation in a collaboration with the Vaccine Formulation Institute and the...


10 May, 2019, 18:45 BST Positive Phase II Data Further Highlights Clinical Proof of Concept for Evobrutinib, First Oral Bruton´s Tyrosine Kinase (BTK) Inhibitor to Report Positive Phase II Clinical Results in MS

Merck, a leading science and technology company, today announced new 48-week results of the double-blind, randomised, placebo-controlled, Phase II...


28 Mar, 2019, 08:13 GMT Merck Invests in Expansion of Manufacturing Capacity for Biotech Medicines

Merck, a leading science and technology company, today announced an investment of €150 million (165 million Swiss francs) in its manufacturing site...


20 Mar, 2019, 09:30 GMT Merck Opens First M Lab™ Collaboration Center in Europe

Merck, a leading science and technology company, today officially opened its new M Lab™ Collaboration Center in Molsheim, France. The center is...


19 Mar, 2019, 10:30 GMT Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China

Merck, a leading science and technology company, today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech...


04 Mar, 2019, 13:00 GMT Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

Merck, a leading science and technology company and leader in genome editing, today announced that the Canadian Patent Office has allowed Merck's...


19 Feb, 2019, 13:00 GMT Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method

Merck, a leading science and technology company and leader in genome editing, today announced that the United States Patent and Trademark Office has...


10 Dec, 2018, 16:30 GMT Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models

Merck, a leading science and technology company and leader in genome editing, today announced a strategic alliance in the CRISPR/Cas9 rodent model...


27 Nov, 2018, 13:00 GMT Merck Wins Two R&D 100 Awards for Innovation in 2018

Merck, a leading science and technology company, today announced that it has won two R&D 100 Awards. The 56th annual R&D 100 Awards program, honoring ...


23 Nov, 2018, 09:00 GMT New campaign supporting UK carers to recognise their role launched

Merck, a leading science and technology company, today announced that its Embracing Carers™ initiative has launched a new campaign to help...


06 Nov, 2018, 08:00 GMT Embracing Carers™ expands support for carers worldwide

Merck today announced the continued expansion of Embracing Carers™. The global initiative, led by Merck in collaboration with leading carer...


05 Nov, 2018, 15:00 GMT Merck Launches BioContinuum™ Platform for Next-Generation Process Improvements

Merck, the vibrant science and technology company, today launched its new BioContinuum™ Platform to advance biotherapeutic drug manufacturing through ...


18 Oct, 2018, 11:15 BST Merck Announces Agreement to Sell Amnis® Flow Cytometry and Guava® Technologies Businesses to Luminex Corporation

Merck, the vibrant science and technology company, today announced the signing of a definitive agreement to sell its Flow Cytometry unit to Luminex...


17 Oct, 2018, 12:17 BST Merck Inaugurates State-of-the-art Pharma Packaging Center in Darmstadt

Expansion of the pharma manufacturing site at Merck's headquarters supports growth of current and future portfolio of pharma medicines New building...


11 Oct, 2018, 18:30 BST Global Survey and Documentary Film Expose Emotional Impact of Multiple Sclerosis

Not intended for U.S media Merck-sponsored survey developed in collaboration with IACO and Eurocarers reveals lifelong effects of caring for a loved...


04 Oct, 2018, 13:00 BST Merck Opens M Lab™ Collaboration Center in São Paulo, Brazil

Merck, the vibrant science and technology company, today officially opened a state-of-the-art M Lab™ Collaboration Center in Brazil, serving the...


15 Aug, 2018, 13:00 BST Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology

Merck, the vibrant science and technology company, today announced that the Australian Patent Office has allowed the company's patent application for ...


26 Jul, 2018, 08:00 BST Merck Receives Recommendation for Approval in 21 EU Countries for the New Formulation of Euthyrox®

Not intended for UK- or US-based media German Federal Institute for Drugs and Medical Devices (BfArM) recommends new formulation of Euthyrox® for...


03 Jul, 2018, 09:15 BST Merck Launches Online Platform Fertility.com

Not intended for U.S. based media Fertility.com is the gateway to two online portals: Offering the latest scientific information to healthcare...


02 Jul, 2018, 12:15 BST Merck Launches Two New Technologies for Improved Efficiency in Fertility Labs

Not intended for U.S. based media QBOX IVF streamlines data transfer between lab instruments and Electronic Medical Record providers Geri® Assess 2.0 ...